Difficulties in diagnosing colorectal cancer with ovarian metastasis: a literature review
DOI:
https://doi.org/10.33448/rsd-v10i16.23904Keywords:
Colorectal cancer; Ovarian metastasis; Diagnosis.Abstract
The process in which colorectal cancer (CRC) is metastasized to the ovary remains unclear. However, it is considered that, as there is no lymphatic flow between the colon and the ovaries, both hematogenous and disseminated peritoneal metastases present possible metastatic pathways. This study has as objective to describe the difficulties and how the diagnosis of colorectal cancer with ovarian metastasis is done. This work was carried out through the Virtual Health Library (VHL) at Pubmed and Medline databases, using the crossings of the descriptors in English “Colorectal cancer”, “Ovarian metastasis”, and “Diagnosis”. To evaluate the research problem and its stratification, it was used the PVO strategy, which can be seen in Table 1. Such strategy permitted the formulation of the following guiding question: “How is the diagnosis of colorectal cancer with ovarian metastasis done?”. Differential diagnosis between primary tumors and ovarian metastases is often difficult. Symptoms associated with the development of ovarian cancer can hide an intestinal disease. Serum values of carbohydrate antigen tumor markers (CA-125) and carcinoembryonic antigen (CEA) have an important role in differentiating patients with primary CRC with ovarian metastasis. Although difficult, the differential diagnosis must be done early to minimize complications. Diagnostic alternatives include histopathological evaluation with the identification of metastatic histological subtypes similar to primary colorectal cancer subtypes, being mucinous adenocarcinoma the most common.
References
Al-Busaidi, I. S., Bailey, T., Dobbs, B., Eglinton, T. W., Wakeman, C. J., & Frizelle, F. A. (2019). Complete resection of colorectal cancer with ovarian metastases combined with chemotherapy is associated with improved survival. ANZ J Surg. 89(9):1091-1096.
Aqsa, A., Droubi, S., Amarnath, S., Haddad, F., & Deeb, L. (2021). Colorectal Metastasis from Ovarian Neoplasm Mimicking Primary Colon Cancer. Case Rep Gastroenterol. 21;15(1):41-46.
Bakkers, C., Van der Meer, R., Roumen, R. M., Lurvink, R. J., Lemmens, V. E., Van Erning, F. N., & Hingh, I. H. (2020). Incidence, risk factors, treatment, and survival of ovarian metastases of colorectal origin: a Dutch population-based study. Int J Colorectal Dis, 35(6): 1035-1044.
Fillmann, L. S., Fillmann, H. S., Fillmann, L. P., Tubiana, A. P. R., Ribeiro, R. & Coelho, M. (2021). Ovarian Metastasis from Colorectal Adenocarcinoma. J Coloproctol ,41(2):176–18.
Galanopoulos, M., Gkeros, F., Liatsos, C., Pontas, C., Papaefthymiou, A., Viazis, N., Mantzaris, G. J., & Tsoukalas, N. (2018). Secondary metastatic lesions to colon and rectum. Annals of gastroenterology, 31(3), 282–287.
Galanopoulos, M., Tsoukalas, N., Papanikolaou, I. S., Tolia, M., Gazouli, M., & Mantzaris, G. J. (2017). Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature. World journal of gastrointestinal oncology, 9(4), 142–152.
Galvão, C. M., Mendes, K. D. S., Silveira, R. C. C. P. (2010) Revisão integrativa: método de revisão para sintetizar as evidências disponíveis na literatura. In: Brevidelli MM, Sertório SCM. Trabalho de conclusão de curso: guia prático para docentes e alunos da área da saúde. 105-26.
Ganesh, K., Shah, R. H., Vakiani, E., Nash, G. M., Skottowe, H. P., Yaeger, R., Cercek, A., Lincoln, A., Tran, C., Segal, N. H., Reidy, D. L., Varghese, A., Epstein, A. S., Sonoda, Y., Chi, D., Guillem, J., Temple, L., Paty, P., Hechtman, J., Shia, J., Weiser, M., Aguilar, J. G., Kemeny, N., Berger, M. F., Saltz, L., & Stadler, Z. K. (2017). Clinical and genetic determinants of ovarian metastases from colorectal cancer. Cancer, 123(7), 1134–1143.
Kubeček, O., Laco, J., Špaček, J., Petera, J., Kopecký, J., Kubečková, A., & Filip, S. (2017). The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. Clinical & experimental metastasis, 34(5), 295–307.
Kurokawa, R., Nakai, Y., Gonoi, W., Makise, N., Ushiku, T., & Abe, O. (2020). Differentiation between ovarian metastasis from colorectal carcinoma and primary ovarian carcinoma: Evaluation of tumour markers and “mille-feuille sign” on computed tomography/magnetic resonance imaging. European Journal of Radiology. 124:108823.
Lee, K. C., Lin, H., Chang, C. C., Fu, H. C., Tsai, C. C., Wu, C. H. & Ou. Y. C. (2017) Difficulty in diagnosis and different prognoses between colorectal cancer with ovarian metastasis and advanced ovarian cancer: An empirical study of different surgical adoptions. Taiwan J Obstet Gynecol. 56(1):62-67.
Li, X., Huang, H., Ran, L., Fang, C., Yu, Y., Luo, M., & Qiu, M. (2020). Impact of Ovarian Metastatectomy on Survival Outcome of Colorectal Cancer Patients with Ovarian Metastasis: A Retrospective Study. Cancer management and research, 12, 4493–4501.
Mori, Y., Nyuya, A., Yasui, K., Toshima, T., Kawai, T., Taniguchi, F., Kimura, K., Inada, R., Nishizaki, M., Haraga, J., Nakamura, K., Umeda, Y., Kishimoto, H., Fujiwara, T., Katata, Y., Yamaguchi, Y., & Nagasaka, T. (2018). Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profiles. Oncotarget, 9(23), 16477–16488.
Mei, D., Zhu, Y., Zhang, L., & Wei, W. (2020). The Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progression and Metastasis. Mediators of inflammation.
Meagher, N. S., Wang, L., Rambau, P. F., Intermaggio, M. P., Huntsman, D. G., Wilkens, L. R., El-Bahrawy, M. A., Ness, R. B., Odunsi, K., Steed, H., Herpel, E., Anglesio, M. S., Zhang, B., Lambie, N., Swerdlow, A. J., Lubiński, J., Vierkant, R. A., Goode, E. L., Menon, U., Toloczko-Grabarek, A., … Köbel, M. (2019). A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc, 32(12), 1834–1846.
Paramythiotis, D., Goulas, P., Moysidis, M., Karakatsanis, A., Tzioufa-Asimakopoulou, V., Sotiriou, S., & Michalopoulos, A. (2019). Metachronous Ovarian Metastases in a Patient with Primary Colorectal Cancer. A Case Report and Review of the Literature. The American journal of case reports, 20, 1515–1520.
Ueda, K., Shinji, S., Yamada, T., Koizumi, M., Matsuda, A., Ohta, R., Yokoyama, Y., Takahashi, G., Hotta, M., Takeda, K., Hara, K., Kuriyama, S., & Yoshida, H. (2019). Consideration for Prognostic Indicators of Ovarian Metastasis of Colorectal Cancer. Gan To Kagaku Ryoho. (13):2386-2388.
Ursem, C., Zhou, M., Paciorek, A., Atreya, C. E., Ko, A. H., Venook, A., Zhang, L., & Van Loon, K. (2020). Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer. Oncologist. 25(7):564-571.
Shimazaki, J., Tabuchi, T., Nishida, K., Takemura, A., Motohashi, G., Kajiyama, H., & Suzuki, S. (2016). Synchronous ovarian metastasis from colorectal cancer: A report of two cases. Oncology letters, 12(1), 257–261.
Zhou, R., Liu, Y., Wang, Y., Huo, X., Zhu, J., & Zhang, T. (2020). Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience. Int J Clin Oncol. 25(10):1822-1829.
Zhou, F. & Ding, J. (2021). Prognosis and factors affecting colorectal cancer with ovarian metastasis. Updates Surg.73(2):391-398.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Noé Araujo Fortes Neto; Ana Klara Rodrigues Alves; Barbara Beatriz Lira da Silva; Lívia Filomena Castelo Branco Machado; Edmar José Fortes Júnior ; Amanda Milhomem Medeiros; Mariana Fagan Peyrot ; Pâmela de Sousa Melo; Victor Rocha Santos; Lizandra Azevedo Brito; Myrcia Ferreira Lopes Nogueira; Gabriel Brito da Silva; Tatiany de Sampaio Fontenele ; Pedro Henrique Fréres Holanda; Ayrton Galvão de Araújo Júnior
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
